A chromobacter is an emerging pathogen in cystic fibrosis (CF) patients, but accurate species identification of isolates is difficult. Most Achromobacter clinical isolates are designated as Achromobacter xylosoxidans; however, the commonly used phenotypic tests are not reliable (1-3). Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis is used in clinical microbiology laboratories as an emerging technology for bacterial species identification (4-8). Genotypic methods have also been developed for Achromobacter species. The amplification of an inner fragment of the bla OXA-114 gene has been proposed for A. xylosoxidans identification (9). Furthermore, the presence of bla , bla , and bla OXA-243 has been detected in Achromobacter ruhlandii, Achromobacter dolens, and Achromobacter insuavis, respectively (2, 3). Multilocus sequence typing (MLST) schemes that increase the accuracy of the characterization and identification of Achromobacter strains and species have also been developed (10, 11) . This study compares the identification of Achromobacter species from CF patients by bla OXA-114 gene sequencing, MLST, and MALDI-TOF MS.
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Twenty-eight archived isolates that had been collected between 2003 and 2008 from 16 CF patients attending two reference centers in Rio de Janeiro, Brazil, were included. The isolates were identified as A. xylosoxidans by 16S rRNA gene sequencing (12, 13) ; bla OXA-114-like gene amplification and sequencing were performed as described by Turton et al. (9) . MLST analysis by sequencing of seven housekeeping genes (nusA, rpoB, eno, gltB, lepA, nuoL, and nrdA) was performed as described previously (11) . Allelic profiles and sequence types (STs) were analyzed according to the PubMLST databases (http://pubmlst.org/achromobacter). MALDI-TOF MS identification was performed with a Microflex LT instrument (Bruker Daltonics, GmbH, Germany) using FlexControl 3.0 software (Bruker Daltonics). Scores of Ն2.0 indicated species-level identification, scores of 1.7 to 1.9 indicated genuslevel identification, and scores of Ͻ1.7 indicated no reliable identification (14, 15) .
Positive bla OXA-114 amplification was obtained for 26 isolates. In 17 isolates, amplicons showed 99 to 100% identity with the bla OXA-114 reference sequence. In 9 isolates, identified as A. ruhlandii, sequences displayed 99% identity with bla OXA-258 . Two isolates (isolates 4530 and 7393) were negative for bla OXA . As observed by Papalia et al. (2) , in our study not only A. xylosoxidans but also A. ruhlandii yielded positive amplification for the A. xylosoxidans species-specific marker bla . Amplification of the inner fragment without sequence analysis, as initially described by Turton et al. (9) , thus may result in the misidentification of some Achromobacter species; by this criterion, we would have identified 26 isolates instead of 17 as A. xylosoxidans. MALDI-TOF MS identified 89% of the isolates (25/28 isolates) as A. xylosoxidans, while 7% (2/28 isolates) were identified at the probable genus level and one (with a score of 1.666) could not be identified (Table 1 ). MLST analysis identified 4 different species and 14 different STs among 28 isolates; 17 (61%) were A. xylosoxidans (ST2, ST13, ST198, ST200, ST201, ST202, ST205, ST206, and ST207), 9 (32%) A. ruhlandii (ST35, ST36, and ST204), one A. dolens (ST199), and one A. insuavis (ST203). Ten new STs and two new allelic arrangements were identified and added to the PubMLST database (http://pubmlst.org/perl/bigsdb /bigsdb.pl?dbϭpubmlst_achromobacter_seqdef&pageϭquery &scheme_idϭ1) ( Table 2) .
Bacterial misidentification is especially problematic and presents a challenge to effective infection control in CF (11) . With 16S rRNA gene sequencing as the sole criterion, 11 (39%) of our isolates would be wrongly identified as A. xylosoxidans. Furthermore, comparative analyses of 16S rRNA gene sequences are of limited value, as all known Achromobacter species exhibit less than 1% sequence dissimilarity with respect to each other (16) . The MALDI-TOF MS results were 39% discordant with MLST identification. All A. ruhlandii (n ϭ 9), A. dolens (n ϭ 1), and A. insuavis (n ϭ 1) isolates were incorrectly identified as A. xylosoxidans (Table 1) , probably due to limitations of the database used, such as the lack of identification spectra for the reference strains (6) . In our samples, we found ST2 and ST13, STs that were detected in CF patients in the United States between 2009 and 2010. We also detected ST36, an ST that was previously isolated in the United States (2004) and Russia (2013), in a non-CF patient and a CF patient, respectively (http://pubmlst .org/perl/bigsdb/bigsdb.pl?dbϭpubmlst_achromobacter_seqdef &pageϭquery&scheme_idϭ1). Furthermore, we also observed ST35, which was first described in 1998 in a non-CF patient in the 12 , ST200/ST201; patient 15, ST2/ST200). These STs differ by five alleles in five genes, suggesting that no intrapatient adaptation occurred. Chronic colonization by clonally related A. xylosoxidans isolates has been described (13, 20) , but the isolation of different species or different STs within a species is original. Moreover, for the first time we demonstrate chronic colonization by clonally related A. ruhlandii isolates in Brazilian CF patients.
